Eckert & Ziegler SE — Cyborg Score 8/10

Strong
Biotechnology / Medical Devices - Radiopharmaceuticals & Isotope Technology

Strategic Profile

The company operates through three segments: Radiation Therapy (producing brachytherapy products through subsidiary Eckert & Ziegler BEBIG), Isotope Products (providing sealed and unsealed radiation sources for medical imaging and industrial applications), and Radiopharma (specializing in molecular imaging and nuclear medicine). This diversified portfolio positions the company as an integrated provider across the isotope technology value chain.

Cyborg Score Rationale

The company demonstrated 20.22% revenue growth to €295.85M in 2024 with earnings increasing 26.52%, indicating strong operational leverage and market demand. Positioned in high-growth radiopharmaceutical and cancer therapy markets with strategic partnerships and recent contract wins supporting expansion.

Top Insights

  • Revenue grew 20.22% year-over-year to €295.85M in 2024, outpacing market growth rates
  • Strategic collaboration with Telix Pharmaceuticals for actinium-225 production using cyclotron-based systems (Nov 2024)
  • Corporate restructuring completed with name change to SE status in March 2024, signaling evolution to scaled operations
  • Diversified revenue streams across brachytherapy implants, radiopharmaceuticals, diagnostic generators, and industrial isotope sources reduce customer concentration risk

Named Competitors

  • Molybdenum-99 and Technetium-99m Generators — Diagnostic nuclear medicine imaging agents
  • Brachytherapy Devices — Cancer radiation therapy systems
  • Radiopharmaceuticals — Therapeutic and diagnostic isotope products

Recent Developments

  • (December 2025) Executive Board reorganization announced
  • (April 2025) Contract manufacturing agreement signed with Pentixapharm for Yttrium-90-based therapeutic products
  • (November 2024) Technology collaboration agreement with Telix Pharmaceuticals for actinium-225 isotope production

Open the full interactive Eckert & Ziegler SE report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →